3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesSkin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, systemic lupus erythematosusRecruitingPhase 22026-10-05NCT06570798
Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric InjuryDigestive System Diseases, Elimination Disorders, Encopresis, Fecal Incontinence, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, digestive system disorder, intestinal disorder, psychiatric disorder, rectal disorderActive, not recruitingPhase 32026-07-21NCT05776277
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid TumorsSolid TumorActive, not recruitingPhase 22025-10-14NCT05642780